- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 49.34M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $153.81M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $198.49M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $283.42M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $253.34M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.98B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.95B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $422.68M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $482.1M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $3.12B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.17B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 47.42M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $40.88M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $19.22M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $500.64M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $609.56M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$1.38 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$1.38 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $76.7M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$59.39M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $168.93M |